• Jobs
  • Startups
  • Hire
LoginSign up

Nabla Bio

Organization banner, image 1 of 3
Organization banner, image 2 of 3
Organization banner, image 3 of 3

Nabla Bio has 3 open roles. Funding stage: Series C. Last round: $70M, Jun 17, 2025.

Open roles

  • Nabla Bio logo
    AI Platform Engineer

    Nabla Bio

    • Boston, MA
    • On-site · Senior
    AI-native
    Gem
    Posted 445d ago
  • Nabla Bio logo
    AI Scientist

    Nabla Bio

    • Boston, MA
    • On-site · Senior
    AI-native
    Gem
    Posted 445d ago
  • Nabla Bio logo
    Applied AI/Bio Scientist

    Nabla Bio

    • Boston, MA
    • On-site · Mid-level
    AI-native
    Gem
    Posted 445d ago

About

Nabla Bio logo

Nabla Bio

Designing antibodies with atomic precision

We develop AI and wet-lab technologies that enable the rational design of developable, selective, and functional drugs against previously undruggable targets. To maximize the patient impact of our platform, we collaborate with leading pharmaceutical companies, including AstraZeneca, Bristol Myers Squibb and Takeda, to expand their pipelines with high-quality drug candidates. If successful we could double the number of disease-relevant drug targets the industry advances for drug development. Since launching in 2021 we have raised $37 million with the backing of leading investors, including Radical Ventures, Khosla Ventures and Zetta Venture Partners. Our technical team is based in Cambridge, Massachusetts and continues to recruit top machine learning and synthetic biology talent. For more information check out the Careers section of our website at www.nabla.bio.

Private companySeries CYC S20Tiny team, big raiseAI-product
Unlock human wisdom
ThesisTermsPrivacy
HQCambridge, United States
Size23 employees
IndustryBiotechnology
Funding
  • Series C · $70M · Jun 17, 2025
  • Series A · $26M · May 14, 2024
Investors
Radical VenturesHV Capital

Claim nabla.bio

Work at nabla.bio? Sign in to claim this org and manage its profile.

© 2026 Saywise Inc.